• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯中部56632名婴儿中新生儿筛查疾病的发病率。一项为期6年的研究。

Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study.

作者信息

Mohamed Sarar, Elsheikh Wafa, Al-Aqeel Aida I, Alhashem Amal M, Alodaib Ali, Alahaideb Lujane, Almashary Maher, Alharbi Fahad, AlMalawi Horia, Ammari Amer, Almohaimeed Sulaiman

机构信息

Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia. E-mail.

出版信息

Saudi Med J. 2020 Jul;41(7):703-708. doi: 10.15537/smj.2020.7.25147.

DOI:10.15537/smj.2020.7.25147
PMID:32601637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7502916/
Abstract

OBJECTIVES

To determine the incidence of newborn screening (NBS) disorders and to study the key performance indicators of the program.

METHODS

This retrospective single-center study enrolled all infants who underwent NBS from January 2012 to December 2017 at Prince Sultan Military Medical City, Riyadh, Saudi Arabia. We screened 17 NBS disorders. Blood samples were collected 24 hours after birth. If the initial result was positive, a second sample was collected. True positive cases were immediately referred for medical management. Data were extracted from laboratory computerized and non-computerized records using case report forms.

RESULTS

During the study period, 56632 infants underwent NBS with a coverage rate of 100%. Thirty-eight cases were confirmed. The incidence of congenital hypothyroidism was 1:3775. The positive predictive value for the detection of congenital hypothyroidism was 11.8%. Propionic aciduria was the most common metabolic disorder, with an incidence of 1:14158. Very long-chain acyl CoA dehydrogenase deficiency and glutaric aciduria type 1 had an incidence of 1:18877 each. Phenylketonuria, biotinidase deficiency, maple syrup urine disease, and citrullinemia had an incidence of 1:28316 each. However, galactosemia and 3-methyl crotonyl carboxylase deficiency had the lowest incidence of 1:56632.

CONCLUSION

The NBS coverage rate at our facility was 100%. Congenital hypothyroidism was the most frequently detected disorder with an incidence that matches worldwide figures. The incidence of other inherited disorders was consistent with regional figures.

摘要

目的

确定新生儿筛查(NBS)疾病的发病率,并研究该项目的关键绩效指标。

方法

这项回顾性单中心研究纳入了2012年1月至2017年12月在沙特阿拉伯利雅得苏丹王子军事医疗城接受新生儿筛查的所有婴儿。我们筛查了17种新生儿筛查疾病。出生后24小时采集血样。如果初始结果为阳性,则采集第二份样本。真正的阳性病例立即转诊接受医疗处理。使用病例报告表从实验室计算机化和非计算机化记录中提取数据。

结果

在研究期间,56632名婴儿接受了新生儿筛查,覆盖率为100%。确诊38例。先天性甲状腺功能减退症的发病率为1:3775。先天性甲状腺功能减退症检测的阳性预测值为11.8%。丙酸尿症是最常见的代谢紊乱疾病,发病率为1:14158。极长链酰基辅酶A脱氢酶缺乏症和1型戊二酸尿症的发病率均为1:18877。苯丙酮尿症、生物素酶缺乏症、枫糖尿症和瓜氨酸血症的发病率均为1:28316。然而,半乳糖血症和3-甲基巴豆酰羧化酶缺乏症的发病率最低,为1:56632。

结论

我们机构的新生儿筛查覆盖率为100%。先天性甲状腺功能减退症是最常检测到的疾病,其发病率与全球数据相符。其他遗传性疾病的发病率与区域数据一致。

相似文献

1
Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study.沙特阿拉伯中部56632名婴儿中新生儿筛查疾病的发病率。一项为期6年的研究。
Saudi Med J. 2020 Jul;41(7):703-708. doi: 10.15537/smj.2020.7.25147.
2
Ethnic variability in newborn metabolic screening markers associated with false-positive outcomes.与假阳性结果相关的新生儿代谢筛查标志物的种族变异性。
J Inherit Metab Dis. 2020 Sep;43(5):934-943. doi: 10.1002/jimd.12236. Epub 2020 Apr 17.
3
Expanded newborn screening in New South Wales: missed cases.新南威尔士州扩大新生儿筛查:漏诊病例
J Inherit Metab Dis. 2014 Nov;37(6):881-7. doi: 10.1007/s10545-014-9727-2. Epub 2014 Jun 27.
4
Next generation sequencing as a follow-up test in an expanded newborn screening programme.在扩大的新生儿筛查项目中,将下一代测序作为后续检测手段。
Clin Biochem. 2018 Feb;52:48-55. doi: 10.1016/j.clinbiochem.2017.10.016. Epub 2017 Oct 27.
5
Molecular and clinical characteristics of very-long-chain acyl-CoA dehydrogenase deficiency: A single-center experience in Saudi Arabia.极长链酰基辅酶A脱氢酶缺乏症的分子与临床特征:沙特阿拉伯的单中心经验
Saudi Med J. 2020 Jun;41(6):590-596. doi: 10.15537/smj.2020.6.25131.
6
[New Inborn Errors of Metabolism added in the French program of neonatal screening].[法国新生儿筛查项目新增的先天性代谢缺陷病]
Med Sci (Paris). 2021 May;37(5):507-518. doi: 10.1051/medsci/2021057. Epub 2021 May 18.
7
Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.新生儿极长链酰基辅酶 A 脱氢酶缺乏症筛查对遗传、酶学和临床结局的影响。
J Inherit Metab Dis. 2019 May;42(3):414-423. doi: 10.1002/jimd.12075. Epub 2019 Apr 8.
8
Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.通过在中国北方人群中扩大新生儿筛查,研究脂肪酸 β-氧化障碍患者的遗传特征和随访情况。
J Pediatr Endocrinol Metab. 2020 May 24;33(6):683-690. doi: 10.1515/jpem-2019-0551.
9
Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.新生儿筛查疑诊极长链酰基辅酶 A 脱氢酶缺乏症的婴儿。
Mol Genet Metab. 2014 Apr;111(4):484-92. doi: 10.1016/j.ymgme.2014.01.009. Epub 2014 Jan 23.
10
Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.扩张型新生儿筛查时代的脂肪酸β-氧化障碍的随访。
Eur J Pediatr. 2019 Mar;178(3):387-394. doi: 10.1007/s00431-018-03315-2. Epub 2019 Jan 7.

引用本文的文献

1
Characterization of C5 Acylcarnitines and Related Dicarboxylic Acylcarnitines in Saudi Newborns: Screening, Confirmation, and Cutoff Variation.沙特新生儿中C5酰基肉碱及相关二羧酸酰基肉碱的特征:筛查、确认及临界值变化
Int J Neonatal Screen. 2025 May 12;11(2):36. doi: 10.3390/ijns11020036.
2
Incidence of Inborn Errors of Metabolism and Endocrine Disorders Among 40965 Newborn Infants at Riyadh Second Health Cluster of the Ministry of Health Saudi Arabia.沙特阿拉伯卫生部利雅得第二健康集群40965名新生儿中先天性代谢缺陷和内分泌疾病的发病率。
Int J Neonatal Screen. 2024 Oct 16;10(4):72. doi: 10.3390/ijns10040072.
3
Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives.生物素稳态与人类疾病:最新发现与展望。
Int J Mol Sci. 2024 Jun 14;25(12):6578. doi: 10.3390/ijms25126578.
4
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).《2024年全球新生儿血斑筛查现状:2020 - 2023年近期活动综合回顾》
Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.
5
Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey.香港扩大新生儿遗传代谢病筛查:七年历程的结果与成果
Int J Neonatal Screen. 2024 Mar 11;10(1):23. doi: 10.3390/ijns10010023.
6
Recent Advances in Phenylketonuria: A Review.苯丙酮尿症的最新进展:综述
Cureus. 2023 Jun 15;15(6):e40459. doi: 10.7759/cureus.40459. eCollection 2023 Jun.
7
Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France.原发性肉碱缺乏症的新生儿筛查:法国在扩大新生儿筛查之前,对全球实践及缺陷进行概述以确定算法。
Int J Neonatal Screen. 2023 Feb 1;9(1):6. doi: 10.3390/ijns9010006.
8
Acute encephalopathy in a 6-year-old child with concurrent COVID-19 infection: a case report from Saudi Arabia.6 岁儿童并发 COVID-19 感染的急性脑病:来自沙特阿拉伯的病例报告。
Int J Infect Dis. 2022 Oct;123:76-79. doi: 10.1016/j.ijid.2022.08.013. Epub 2022 Aug 23.
9
Insights into National Laboratory Newborn Screening and Future Prospects.国家实验室新生儿筛查的见解与未来展望。
Medicina (Kaunas). 2022 Feb 11;58(2):272. doi: 10.3390/medicina58020272.
10
Spectrum of Genetic Diseases in Tunisia: Current Situation and Main Milestones Achieved.突尼斯的遗传疾病谱:现状与主要成就
Genes (Basel). 2021 Nov 19;12(11):1820. doi: 10.3390/genes12111820.

本文引用的文献

1
Newborn Screening for Primary Congenital Hypothyroidism: Estimating Test Performance at Different TSH Thresholds.新生儿先天性甲状腺功能减退症筛查:不同 TSH 阈值下的检测性能评估。
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3720-3728. doi: 10.1210/jc.2018-00658.
2
Expanded Newborn Screening Programme in Saudi Arabia: Are We Ready?沙特阿拉伯扩大新生儿筛查项目:我们准备好了吗?
J Paediatr Child Health. 2017 Dec;53(12):1242. doi: 10.1111/jpc.13747.
3
Reflection on the Expanded Newborn Screening Programme in Saudi Arabia: Incidence of Screened Disorders.沙特阿拉伯扩大新生儿筛查项目的反思:筛查疾病的发病率
J Paediatr Child Health. 2017 Oct;53(10):1034-1035. doi: 10.1111/jpc.13669.
4
Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?先天性甲状腺功能减退症新生儿筛查中较低的促甲状腺激素(TSH)临界值是否合理?
Eur J Endocrinol. 2017 Nov;177(5):D1-D12. doi: 10.1530/EJE-17-0107. Epub 2017 Jul 10.
5
Expanded Newborn Screening Program in Saudi Arabia: Incidence of screened disorders.沙特阿拉伯扩大新生儿筛查项目:筛查疾病的发病率
J Paediatr Child Health. 2017 Jun;53(6):585-591. doi: 10.1111/jpc.13469. Epub 2017 Mar 24.
6
Overview of diagnosis, management and outcome of congenital hypothyroidism: A call for a national screening programme in Sudan.先天性甲状腺功能减退症的诊断、管理及预后概述:呼吁苏丹开展全国筛查计划。
Sudan J Paediatr. 2012;12(2):7-16.
7
Prediction of congenital hypothyroidism based on initial screening thyroid-stimulating-hormone.基于初始筛查促甲状腺激素对先天性甲状腺功能减退症的预测
BMC Pediatr. 2016 Feb 2;16:24. doi: 10.1186/s12887-016-0559-0.
8
Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011.将阿联酋的全国新生儿综合筛查计划从 1995 年扩大到 2011 年。
East Mediterr Health J. 2014 Feb 11;20(1):17-23.
9
Newborn screening for inborn errors of metabolism in mainland china: 30 years of experience.中国大陆新生儿遗传代谢病筛查:30年经验
JIMD Rep. 2012;6:79-83. doi: 10.1007/8904_2011_119. Epub 2012 Jan 31.
10
Enhanced interpretation of newborn screening results without analyte cutoff values.无需分析物截断值即可增强新生儿筛查结果的解读。
Genet Med. 2012 Jul;14(7):648-55. doi: 10.1038/gim.2012.2. Epub 2012 Feb 16.